Boston Scientific Corp (BSX) Analysts | Reuters.com
Edition:
United States

Boston Scientific Corp (BSX)

BSX on New York Consolidated

22.37USD
24 Jun 2016
Change (% chg)

$-0.60 (-2.61%)
Prev Close
$22.97
Open
$22.35
Day's High
$22.95
Day's Low
$22.30
Volume
39,356,606
Avg. Vol
9,920,998
52-wk High
$23.35
52-wk Low
$14.18

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform 0.26 December 25 Jun 2016

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 10 10 10 10
(2) OUTPERFORM 12 12 12 13
(3) HOLD 6 5 5 5
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 1.86 1.81 1.81 1.82

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Jun-16 24 2,045.52 2,081.50 2,016.00 1,904.55
Quarter Ending Sep-16 24 2,043.60 2,080.05 2,012.30 1,913.12
Year Ending Dec-16 27 8,168.55 8,303.45 8,091.50 7,672.53
Year Ending Dec-17 27 8,622.75 8,846.62 8,500.00 7,992.96
Earnings (per share)
Quarter Ending Jun-16 27 0.26 0.27 0.26 0.25
Quarter Ending Sep-16 26 0.27 0.29 0.26 0.26
Year Ending Dec-16 29 1.09 1.13 1.06 1.02
Year Ending Dec-17 29 1.24 1.30 1.18 1.14
LT Growth Rate (%) 8 12.70 18.30 8.60 12.02

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Mar-16 1,912.80 1,964.00 51.20 2.68
Quarter Ending Dec-15 1,994.16 1,978.00 16.16 0.81
Quarter Ending Sep-15 1,861.51 1,888.00 26.49 1.42
Quarter Ending Jun-15 1,833.67 1,843.00 9.33 0.51
Quarter Ending Mar-15 1,778.94 1,768.00 10.94 0.61
Earnings (per share)
Quarter Ending Mar-16 0.24 0.28 0.04 15.99
Quarter Ending Dec-15 0.25 0.26 0.01 5.56
Quarter Ending Sep-15 0.23 0.24 0.01 6.15
Quarter Ending Jun-15 0.21 0.22 0.01 2.76
Quarter Ending Mar-15 0.21 0.21 0.00 2.19

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Jun-16 2,045.52 2,045.36 2,044.76 2,008.51 1,904.55
Quarter Ending Sep-16 2,043.60 2,043.20 2,042.42 2,012.29 1,913.12
Year Ending Dec-16 8,168.55 8,167.57 8,165.63 8,011.85 7,672.53
Year Ending Dec-17 8,622.75 8,621.17 8,618.14 8,417.56 7,992.96
Earnings (per share)
Quarter Ending Jun-16 0.26 0.26 0.27 0.26 0.25
Quarter Ending Sep-16 0.27 0.27 0.27 0.27 0.26
Year Ending Dec-16 1.09 1.09 1.09 1.05 1.02
Year Ending Dec-17 1.24 1.24 1.24 1.19 1.14

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Jun-16 1 0 1 0
Quarter Ending Sep-16 1 0 1 0
Year Ending Dec-16 2 0 2 0
Year Ending Dec-17 1 1 1 1
Earnings
Quarter Ending Jun-16 0 0 0 0
Quarter Ending Sep-16 0 0 0 0
Year Ending Dec-16 1 0 1 0
Year Ending Dec-17 1 0 1 0

Analyst Research Reports

Report Title Price
Provider : Stock Traders Daily
$20.00
Provider : Thomson Reuters Stock Report
$25.00
Provider : Stock Traders Daily
$20.00
Provider : New Constructs, LLC
$25.00
Provider : Jefferson Research
$20.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.